Mico BioMed Co. Ltd. Working Capital to Net Assets Ratio
Mico BioMed Co. Ltd. working capital to net assets ratio. Mico BioMed Co. Ltd. (214610) has a Working Capital to Net Assets ratio of 63.2% as of September 2025. Working capital of ₩16.30 Billion (current assets of ₩20.49 Billion minus current liabilities of ₩4.20 Billion) is measured against net assets of ₩25.81 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Mico BioMed Co. Ltd. (214610) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Mico BioMed Co. Ltd. (2015–2024)
Working capital to net assets ratio of Mico BioMed Co. Ltd. from 2015 to 2024. This chart shows how Mico BioMed Co. Ltd.'s Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of September 2025, the ratio stands at 63.2%, reflecting working capital of ₩16.30 Billion against net assets of ₩25.81 Billion KRW. See Mico BioMed Co. Ltd. defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Mico BioMed Co. Ltd. Working Capital to Net Assets Ratio by Year (2015–2024)
Mico BioMed Co. Ltd. working capital to net assets ratio by year from 2015 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Mico BioMed Co. Ltd. from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 214610 total assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 49.3% | ₩12.76 Billion | ₩25.89 Billion | ₩26.71 Billion | ₩13.95 Billion | ▼ -32.9 pp |
| 2023 | 82.2% | ₩29.85 Billion | ₩36.33 Billion | ₩47.39 Billion | ₩17.54 Billion | ▲ +30.7 pp |
| 2022 | 51.4% | ₩9.10 Billion | ₩17.69 Billion | ₩36.53 Billion | ₩27.43 Billion | ▼ -59.5 pp |
| 2021 | 110.9% | ₩57.96 Billion | ₩52.26 Billion | ₩69.68 Billion | ₩11.72 Billion | ▲ +24.4 pp |
| 2020 | 86.6% | ₩48.44 Billion | ₩55.96 Billion | ₩57.31 Billion | ₩8.87 Billion | ▲ +252.6 pp |
| 2019 | -166.0% | ₩-1.69 Billion | ₩1.02 Billion | ₩16.68 Billion | ₩18.38 Billion | ▼ -364.4 pp |
| 2018 | 198.4% | ₩11.33 Billion | ₩5.71 Billion | ₩13.98 Billion | ₩2.64 Billion | ▲ +25.1 pp |
| 2017 | 173.3% | ₩5.92 Billion | ₩3.42 Billion | ₩9.36 Billion | ₩3.43 Billion | ▲ +92.3 pp |
| 2016 | 81.0% | ₩3.10 Billion | ₩3.83 Billion | ₩5.07 Billion | ₩1.98 Billion | ▼ -13.9 pp |
| 2015 | 94.8% | ₩4.65 Billion | ₩4.90 Billion | ₩5.93 Billion | ₩1.29 Billion | — |